Skip to main content

and
  1. Article

    Open Access

    Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada

    Every year, over 1 million people develop isoniazid (INH) resistant tuberculosis (TB). Yet, the optimal treatment regimen remains unclear. Given increasing prevalence, the clinical efficacy of regimens used by...

    Kamila Romanowski, Leslie Y. Chiang, David Z. Roth, Mel Krajden in BMC Infectious Diseases (2017)